New drug could slow progression of Alzheimer's by 80 per cent
Updated on 29 July 2008
British researchers find that a new drug could prove at least twice as effective in treating Alzheimer's as current medicines.
The drug, Rember, slows progression of the disease by as much as 80% and the Alzheimer's Society is hailing it as a major development in the fight against dementia.
The research into the disease, which affects 350,000 people in the UK, was carried out at Aberdeen University.
